Approval · Notice of Compliance 9145 · 2007
PRINZIDE: Notice of Compliance 9145
Issued October 31, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9145
- Date
- October 31, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised indication to support the use of prinzide as initial treatment of essential hypertension for whom combination therapy is appropriate; and other revisions to the product monograph
- Therapeutic class
- Angiotensin converting enzyme inhibitor / diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRINZIDE | Not yet assigned | — |
Medicinal ingredients
- LISINOPRIL 10 MG per TAB
- HYDROCHLOROTHIAZIDE 12.5 MG per TAB
- LISINOPRIL 20 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB